Adicet Bio, Inc. (ACET) Income Annual - Discounting Cash Flows
ACET
Adicet Bio, Inc.
ACET (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
06-30
2016
06-30
2015
06-30
2014
06-30
2013
06-30
2012
06-30
2011
06-30
2010
06-30
2009
06-30
2008
06-30
Report Filing 2025-11-05 2025-03-06 2024-03-19 2023-03-15 2022-03-15 2021-03-12 2020-03-12 2019-03-18 2017-08-25 2016-08-26 2015-09-11 2014-09-05 2013-08-29 2012-09-07 2011-09-09 2010-09-10 2009-09-11 2008-09-05
Revenue 0 0 0 24.99 9.73 17.9 0.995 8.18 558.5 547 510.2 499.7 499.7 444.4 412.4 346.6 322.6 359.6
Cost of Revenue 0 0 0 0 0 0 0 0.08 0.005 411.5 395.5 401.4 401.4 362.4 346.6 292.5 267 292.3
Gross Profit 0 0 0 24.99 9.73 17.9 0.995 8.1 558.5 135.4 114.7 98.27 98.27 82.03 65.84 54.16 55.62 67.31
Operating Expenses 121 127.6 152 97.54 71.16 57.09 32.38 23.07 577.4 135.4 70.43 63.85 63.85 56.67 49.29 44.72 43.73 45.93
Research & Development 97.36 99.32 106 71.25 48.94 34.33 23.69 14.72 16.84 5.94 5.22 2.83 0 0 0 0 0.153 0.506
Selling, General and Administrative 23.61 28.29 26.53 26.3 22.22 22.76 8.69 8.43 2.04 0.001 65.21 61.02 63.85 56.67 49.29 44.72 43.57 45.42
Other Operating Expenses 0 0 19.46 0 0 0 0 -0.08 558.5 129.5 0 0 0 0 0 0 0 0
Operating Income -121 -127.6 -152 -72.55 -61.43 -39.19 -31.39 -14.96 -18.88 -0.001 44.27 34.42 34.42 25.37 16.55 9.44 11.89 21.38
Net Non-Operating Interest 6.31 10.71 9.95 3.68 -0.085 0.651 0.938 0.543 -7 -3.95 -2.1 -2.12 -2.12 -2.63 -1.57 -0.23 -0.098 -0.145
Interest Income 6.32 10.71 9.95 3.76 0.091 0.785 0.938 0.543 0 0 0 0 0 0 0 0 0 0
Interest Expense 0.013 0.004 0 0.08 0.176 0.134 0 0 7 3.95 2.1 2.12 2.12 2.63 1.57 0.23 0.098 0.145
Equity & Other Income/(Expense) -0.349 -0.217 -0.573 -0.919 -0.606 -0.953 2.33 4.53 -7.9 3.95 2.5 2.26 2.26 2 1.98 0.995 0.937 0.957
Income Before Tax -115 -117.1 -142.7 -69.79 -62.12 -39.49 -28.12 -9.89 -33.78 -0.001 44.67 34.55 34.55 24.74 16.96 10.2 12.73 22.19
Income Tax Expense 0 0 0 0 -0.125 -2.81 0.019 -0.589 0 0 15.67 12.22 12.22 7.76 7.99 3.62 4.1 8.72
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income -115 -117.1 -142.7 -69.79 -62 -36.68 -28.14 -9.3 -33.78 -0.001 29 22.33 22.33 16.98 8.97 6.58 8.63 13.47
Depreciation and Amortization 6.53 6.47 6.1 5.01 1.54 1.95 1.24 0.08 0.005 11.85 8.09 6.94 6.94 6.94 5.5 2.8 1.87 2.38
EBITDA -114.4 -121.1 -145.9 -67.54 -59.9 -37.24 -30.15 -14.88 -18.88 11.85 52.36 41.36 41.36 32.31 22.05 12.23 13.76 23.75
Earnings Per Share (EPS) -20.16 -21.28 -52.96 -27.2 -32 -80.16 -24.32 -4.96 -20.16 -0.001 18.88 15.04 15.04 11.68 6.4 4.8 6.4 10.08
Diluted Earnings Per Share -20.16 -21.28 -52.96 -27.2 -32 -80.16 -24.32 -4.96 -20 -0.001 18.56 14.88 14.88 11.52 6.24 4.8 6.24 9.92
Weighted Average Shares Outstanding 5.69 5.49 2.69 2.57 1.93 0.457 1.16 1.86 1.67 1.75 1.53 1.48 1.48 1.45 1.42 1.37 1.34 1.33
Diluted Weighted Average Shares Outstanding 5.69 5.49 2.69 2.57 1.93 0.457 1.16 1.86 1.69 1.75 1.56 1.5 1.5 1.47 1.43 1.38 1.37 1.36
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program